A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Clinical trial NCT06897475 · RECRUITING
Trial details
- NCT number
- NCT06897475
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2026-12-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.